Credence Research Logo

Home » Healthcare » Pharmaceuticals » Marknad för bioengineerade proteindroger

Marknaden för bioengineerade proteindroger efter typ (monoklonala antikroppar, hormoner, cytokiner och interleukiner, koagulationsfaktorer, enzymer, fusionsproteiner, proteinsubenhetsvacciner, andra); efter sjukdomsindikation (onkologi, diabetes och metabola störningar, autoimmuna sjukdomar, infektionssjukdomar, hjärt-kärlsjukdomar, artrit, medfödda sjukdomar, blodsjukdomar, hudsjukdomar, andningssjukdomar, neurodegenerativa sjukdomar); efter expressionssystem (däggdjurscellkultur, mikrobiella expressionssystem, växtbaserade expressionssystem, insektscelluttryckssystem, andra); efter slutanvändare (läkemedelsföretag, bioteknikföretag, kontraktsforskningsorganisationer, forskningsinstitut) – Tillväxt, andel, möjligheter och konkurrensanalys, 2025 – 2032

Report ID: 206232 | Report Format : Excel, PDF

Begär ett gratisprov

Begär gratis prov

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Begär din provrapport och börja din resa mot välgrundade beslut

Tillhandahåller den strategiska kompassen för branschledare.

cr-clients-logos
Vanliga frågor:
Vad är marknadsstorleken för marknaden för bioengineerade proteindroger år 2025 och prognosen för 2032?

Marknaden för bioingenjörda proteindroger hade en storlek på 391 488,41 miljoner USD år 2025. Marknaden för bioingenjörda proteindroger förväntas nå 588 653,82 miljoner USD år 2032.

Vad är CAGR för marknaden för bioengineerade proteinläkemedel under 2025–2032?

Marknaden för bioengineerade proteindroger förväntas växa med en årlig tillväxttakt (CAGR) på 6% under 2025–2032. Tillväxten stöds av fortsatt innovation inom biologiska läkemedel och en ökande klinisk adoption.

Vilket segment är det största på marknaden för bioengineerade proteindroger?

Monoklonala antikroppar är den största produktsegmentet med en marknadsandel på 40,8% år 2025. Ledarskapet stöds av bred klinisk nytta och stark kommersialiseringsmognad.

Vilka faktorer driver tillväxten av marknaden för bioingenjörda proteindroger?

Tillväxten på marknaden för bioengineerade proteinläkemedel drivs av expanderande biologiska pipeline, ökande börda av kroniska sjukdomar och ökad tillverkningskapacitet. Förbättrad ersättningsskydd stödjer också en bredare adoption.

Vilka är de viktigaste aktörerna på marknaden för bioengineerade proteindroger?

Nyckelföretag inkluderar Abbott, AbbVie, Amgen Inc., Bayer AG, Baxter Healthcare, Biocon, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Johnson & Johnson, Merck & Co., Inc., Novartis AG, Novo Nordisk och Sanofi.

Vilken region leder marknaden för bioengineerade proteindroger?

Nordamerika leder marknaden för bioengineerade proteindroger med en andel på 43,70 % år 2025. Ledarskapet stöds av stark tillgång till biologiska läkemedel, kapacitet för specialvård och mogna ersättningssystem.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

North America Respiratory Drugs Market

The North America Respiratory Drugs Market size was valued at USD 4,603.33 MN in 2021 and reached USD 5,912.29 MN in 2025. It is anticipated to reach USD 8,990.65 MN by 2032, growing at a CAGR of 5.07% during the forecast period.

North America CNS Drugs Market

The North America CNS Drugs Market size was valued at USD 29,971.81 MN in 2021 and reached USD 39,376.62 MN in 2025. It is anticipated to reach USD 64,694.22 MN by 2032, growing at a CAGR of 6.13% during the forecast period.

Asia Pacific Gastrointestinal Drugs Market

The Asia Pacific Gastrointestinal Drugs Market size was valued at USD 14,076.07 MN in 2021 and reached USD 18,379.23 MN in 2025. It is anticipated to reach USD 27,675.57 MN by 2032, growing at a CAGR of 4.86% during the forecast period.

North America Immunology Drugs Market

The North America Immunology Drugs Market size was valued at USD 23,174.02 MN in 2021 and reached USD 34,194.85 MN in 2025. It is anticipated to reach USD 70,564.69 MN by 2032, growing at a CAGR of 9.11% during the forecast period.

Europe Anticancer Drugs/Oncology Drugs Market

The Europe Anticancer Drugs/Oncology Drugs Market size was valued at USD 52,704.85 MN in 2021 and reached USD 71,835.97 MN in 2025. It is anticipated to reach USD 125,841.34 MN by 2032, growing at a CAGR of 8.34% during the forecast period.

North America Antidiabetics Drug Market

The North America Antidiabetics Drug Market size was valued at USD 18,811.60 MN in 2021 and reached USD 25,029.65 MN in 2025. It is anticipated to reach USD 42,563.34 MN by 2032, growing at a CAGR of 6.60% during the forecast period.

Dipeptide Peptidase 4 (DPP-4) Inhibitors Market

The Dipeptide Peptidase 4 (DPP-4) Inhibitors Market size was estimated at USD 11,280.60 million in 2025 and is expected to reach USD 15,527.66 million by 2032, growing at a CAGR of 5.47% from 2025 to 2032.

Diphenhydramine Market

The Diphenhydramine Market size was estimated at USD 1,680.45 million in 2025 and is expected to reach USD 2,204.77 million by 2032, growing at a CAGR of 4.63% from 2025 to 2032.

Intraosseous Devices Market

The Intraosseous Devices Market size was valued at USD 448 million in 2024 and is anticipated to reach USD 612.55 million by 2032, growing at a CAGR of 3.98% during the forecast period.

Dilated Cardiomyopathy Therapeutics Market

The Dilated Cardiomyopathy Therapeutic Market size was estimated at USD 5,240.95 million in 2025 and is expected to reach USD 8,025.37 million by 2032, growing at a CAGR of 7.36% from 2025 to 2032.

Divalproex Sodium Market

The Divalproex Sodium Market size was estimated at USD 1,860.58 million in 2025 and is expected to reach USD 2,453.73 million by 2032, growing at a CAGR of 4.72% from 2025 to 2032.

Somatostatin Analogs Market

The global somatostatin analogs market was valued at USD 7,187.5 million in 2024 and is projected to reach USD 12,349.46 million by 2032, expanding at a compound annual growth rate (CAGR) of 7% during the forecast period.

Licensalternativ

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$5999

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$7999

Report delivery within 24 to 48 hours

Snabbkontakt

Europe

+44 7453 598 606

North America

+1 6282 627 656

Email

[email protected]

Begär ett gratisprov

Smallform of Sample request

What people say?

User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materialforskare
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Ledningsassistent, Bekaert

Betrodd av

cr-clients-logos

Request Sample